BioRem Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was CAD 6.26 million compared to CAD 5.63 million a year ago. Net income was CAD 0.16434 million compared to CAD 0.26642 million a year ago. Basic earnings per share from continuing operations was CAD 0.011 compared to CAD 0.007 a year ago. Diluted earnings per share from continuing operations was CAD 0.01 compared to CAD 0.007 a year ago.
For the six months, sales was CAD 10.64 million compared to CAD 9.06 million a year ago. Net income was CAD 0.06402 million compared to net loss of CAD 0.151437 million a year ago. Basic earnings per share from continuing operations was CAD 0.004. Diluted earnings per share from continuing operations was CAD 0.004.